102 related articles for article (PubMed ID: 16465431)
1. Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment in paediatric sarcoma patients: a report from the Late Effects Surveillance System.
Paulides M; Stöhr W; Bielack S; Jürgens H; Koscielniak E; Klingebiel T; Zimmermann R; Stachel D; Langer T; Beck JD
Oncol Rep; 2006 Mar; 15(3):687-91. PubMed ID: 16465431
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System.
Paulides M; Dörr HG; Stöhr W; Bielack S; Koscielniak E; Klingebiel T; Jürgens H; Bölling T; Willich N; Sauer R; Langer T; Beck JD;
Clin Endocrinol (Oxf); 2007 May; 66(5):727-31. PubMed ID: 17381483
[TBL] [Abstract][Full Text] [Related]
3. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
[TBL] [Abstract][Full Text] [Related]
4. Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System.
Paulides M; Stöhr W; Laws HJ; Graf N; Lakomek M; Berthold F; Schmitt K; Niggli F; Jürgens H; Bielack S; Koscielniak E; Klingebiel T; Langer T
Vaccine; 2011 Feb; 29(8):1565-8. PubMed ID: 21219980
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
6. Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS).
Langer T; Stöhr W; Paulides M; Kremers A; Dörr HG; Göbel U; Beck JD
Klin Padiatr; 2005; 217(3):176-81. PubMed ID: 15858710
[TBL] [Abstract][Full Text] [Related]
7. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India.
Hussain T; Kulshreshtha KK; Sinha S; Yadav VS; Katoch VM
Int J Infect Dis; 2006 Sep; 10(5):358-63. PubMed ID: 16678462
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
9. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
10. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
11. Late effects surveillance system for sarcoma patients.
Langer T; Stöhr W; Bielack S; Paulussen M; Treuner J; Beck JD;
Pediatr Blood Cancer; 2004 Apr; 42(4):373-9. PubMed ID: 14966836
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
Tripathi AK; Khanna M; Gupta N; Chandra M
J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca].
Boulaajaj K; Elomari Y; Elmaliki B; Madkouri B; Zaid D; Benchemsi N
Nephrol Ther; 2005 Nov; 1(5):274-84. PubMed ID: 16895696
[TBL] [Abstract][Full Text] [Related]
20. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
